HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Infant Formula Acceptable Nutrient Levels Need Revision – FAC Consultant

This article was originally published in The Tan Sheet

Executive Summary

FDA should amend its infant formula regulations to account for new research on appropriate nutrient intake levels for infants, says Food Advisory Committee consultant Dennis Bier, MD, Baylor College of Medicine, Dallas

You may also be interested in...



Infant Formula Growth Studies Advised For Certain Soy, Iron Sources By FAC

A growth study should be conducted when a soy protein stripped of isoflavones has been added to an infant formula to ensure its safety, Virginia Stallings, MD, Children's Hospital of Philadelphia, theorized

Infant Formula Data Generalizations Inappropriate In Most Cases – FAC

Data on preterm infants should not be applied to term infants in the majority of cases, but exceptions may arise on an individual basis, FDA's Food Advisory Committee said April 4-5

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel